BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Modulatory Effects of Triphala and Manjistha Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study. ✅
Go to Publication ✅
Journal of alternative and complementary medicine (New York, N.Y.) (J Altern Complement Med ) Vol: Issue Pages: Pub: 2020 Sep 18 Epub: 2020 Sep 18 Authors Peterson CT , Pourang A , Dhaliwal S , Kohn JN , Uchitel S , Singh H , Mills PJ , Peterson SN , Sivamani RK , |
|
|
In Vitro Antibacterial Evaluation of Terminalia chebula as an Alternative of Antibiotics against Bovine Subclinical Mastitis. ✅
Go to Publication ✅
Animal biotechnology (Anim Biotechnol ) Vol: 30 Issue 2 Pages: 151-158 Pub: 2019 Apr Epub: 2018 Mar 28 Authors Kher MN , Sheth NR , Bhatt VD , |
|
|
Preventive mechanisms of Chinese Tibetan medicine Triphala against nonalcoholic fatty liver disease. ✅
Go to Publication ✅
Phytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine ) Vol: 123 Issue Pages: 155229 Pub: 2024 Jan Epub: 2023 Nov 20 Authors Jiang Y , Zhao L , Ma J , Yang Y , Zhang B , Xu J , Dhondrup R , Wong TW , Zhang D , |
|
|
Evaluation of in vitro antioxidant, antiglycation and antimicrobial potential of indigenous Myanmar medicinal plants. ✅
Go to Publication ✅
Journal of integrative medicine (J Integr Med ) Vol: 16 Issue 5 Pages: 358-366 Pub: 2018 Sep Epub: 2018 Aug 4 Authors Moe TS , Win HH , Hlaing TT , Lwin WW , Htet ZM , Mya KM , |
|
|
Triphala: A phytomedicine for local drug delivery - A strategic intervention. ✅
Go to Publication ✅
Ayu (Ayu ) Vol: 40 Issue 1 Pages: 53-57 Pub: 2019 Jan-Mar Epub: Authors Shivaprasad BM , Patil P , Nair SK , Singh N , Shivanand S , Sameera U , |
|
|
Terminalia Chebula Extract Replacing Zinc Oxide Enhances Antioxidant and Anti-Inflammatory Capabilities, Improves Growth Performance, and Promotes Intestinal Health in Weaned Piglets. ✅
Go to Publication ✅
Antioxidants (Basel, Switzerland) (Antioxidants (Basel) ) Vol: 13 Issue 9 Pages: Pub: 2024 Sep 5 Epub: 2024 Sep 5 Authors Wang T , Li Y , Yin L , Chen J , Shi P , Wang F , Wu K , Yao K , Yin Y , |
|
|
Antioxidant, antihypertensive, and antibacterial properties of endophytic Pestalotiopsis species from medicinal plants. ✅
Go to Publication ✅
Canadian journal of microbiology (Can J Microbiol ) Vol: 54 Issue 9 Pages: 769-80 Pub: 2008 Sep Epub: Authors Tejesvi MV , Kini KR , Prakash HS , Subbiah V , Shetty HS , |
|
|
Growth-inhibiting activity of active component isolated from Terminalia chebula fruits against intestinal bacteria. ✅
Journal of food protection (J Food Prot ) Vol: 69 Issue 9 Pages: 2205-9 Pub: 2006 Sep Epub: Authors Kim HG , Cho JH , Jeong EY , Lim JH , Lee SH , Lee HS , |
|
|
Growth-inhibiting activity of active component isolated from Terminalia chebula fruits against intestinal bacteria. ✅
Journal of food protection (J Food Prot ) Vol: 69 Issue 9 Pages: 2205-9 Pub: 2006 Sep Epub: Authors Kim HG , Cho JH , Jeong EY , Lim JH , Lee SH , Lee HS , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
